Jim Cramer Says Wait A Little & Discusses These 11 Stocks

Page 5 of 10

6. Moderna, Inc. (NASDAQ:MRNA)

Number of Hedge Fund Holders In Q4 2024: 44

Moderna, Inc. (NASDAQ:MRNA) is a biotechnology company whose shares have been unable to catch a break ever since the coronavirus pandemic ended. The firm’s shares are down by 73% over the past year, and they haven’t caught a break in 2025 either as they have lost 33.8% year-to-date. Moderna, Inc. (NASDAQ:MRNA)’s stock was hit again in March after an FDA official retired. Cramer commented on the development in detail:

“[On MRNA being down after an FDA official resigning] I found that this was really extraordinary. Dedicated official. Obviously gonna be fired or has to leave. Has favored MRNA. MRNA had been part of the discourse to be able to . . .personalized cancer vaccines. If that’s halted. Then I think that you would question the worth of Moderna. David, Moderna. . .problematic. Problematic. . . “

Page 5 of 10